GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Helix BioPharma Corp (TSX:HBP) » Definitions » 6-1 Month Momentum %

Helix BioPharma (TSX:HBP) 6-1 Month Momentum % : -11.36% (As of May. 25, 2024)


View and export this data going back to 1996. Start your Free Trial

What is Helix BioPharma 6-1 Month Momentum %?

6-1 Month Momentum % is the total return of the stock from 6-month ago to 1-month ago. As of today (2024-05-25), Helix BioPharma's 6-1 Month Momentum % is -11.36%.

The industry rank for Helix BioPharma's 6-1 Month Momentum % or its related term are showing as below:

TSX:HBP's 6-1 Month Momentum % is ranked worse than
56.29% of 1526 companies
in the Biotechnology industry
Industry Median: -5.54 vs TSX:HBP: -11.36

Competitive Comparison of Helix BioPharma's 6-1 Month Momentum %

For the Biotechnology subindustry, Helix BioPharma's 6-1 Month Momentum %, along with its competitors' market caps and 6-1 Month Momentum % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Helix BioPharma's 6-1 Month Momentum % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Helix BioPharma's 6-1 Month Momentum % distribution charts can be found below:

* The bar in red indicates where Helix BioPharma's 6-1 Month Momentum % falls into.



Helix BioPharma  (TSX:HBP) 6-1 Month Momentum % Calculation

6-1 Month Momentum % is calculated as following:

6-1 Month Momentum %=( Price 1-month ago / Price 6-month ago - 1 ) * 100 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Helix BioPharma  (TSX:HBP) 6-1 Month Momentum % Explanation

Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 6-1 Month Momentum % measures the total return to a stock over the past six months, but ignores the previous month.

The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.


Helix BioPharma 6-1 Month Momentum % Related Terms

Thank you for viewing the detailed overview of Helix BioPharma's 6-1 Month Momentum % provided by GuruFocus.com. Please click on the following links to see related term pages.


Helix BioPharma (TSX:HBP) Business Description

Traded in Other Exchanges
Address
401 Bay Street, Suite 2704, Toronto, ON, CAN, M5H 2Y
Helix BioPharma Corp is a clinical-stage biopharmaceutical company. It is focused on cancer drug development. The company develops therapies in the field of immuno-oncology based on its proprietary technology mainly in the areas of cancer prevention and treatment. Its pipeline candidates are Tumor Defence Breaker L-DOS47, and, V-DOS47 among others.